share_log

国投证券股份有限公司关于四川百利天恒药业股份有限公司2024年半年度持续督导跟踪报告

SDIC Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Sichuan Baili Tianheng Pharmaceutical Co., Ltd.

SZSI ·  Sep 3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more